Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Joshi S;Joshi S; Shallal A; Shallal A; Zervos M; Zervos M
  • Source:
    Infectious disease clinics of North America [Infect Dis Clin North Am] 2021 Dec; Vol. 35 (4), pp. 953-968.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 8804508 Publication Model: Print Cited Medium: Internet ISSN: 1557-9824 (Electronic) Linking ISSN: 08915520 NLM ISO Abbreviation: Infect Dis Clin North Am Subsets: MEDLINE
    • Publication Information:
      Publication: <2005->: Philadelphia : Elsevier Health Sciences Division
      Original Publication: Philadelphia : W.B. Saunders Co., c1987-
    • Subject Terms:
      Vancomycin-Resistant Enterococci*; Cross Infection/*prevention & control ; Enterococcus/*drug effects ; Gram-Positive Bacterial Infections/*prevention & control ; Vancomycin/*pharmacology; Antimicrobial Stewardship ; Child ; Drug Resistance, Multiple ; Humans ; Infection Control/organization & administration ; Pediatrics ; Vancomycin/therapeutic use
    • Abstract:
      Vancomycin-resistant enterococcus (VRE) is a pathogen of growing concern due to increasing development of antibiotic resistance, increasing length of hospitalizations and excess mortality. The utility of some infection control practices are debatable, as newer developments in infection prevention strategies continued to be discovered. This article summarizes the significance of VRE and VRE transmission, along with highlighting key changes in infection control practices within the past 5 years.
      (Copyright © 2021 Elsevier Inc. All rights reserved.)
    • Contributed Indexing:
      Keywords: Antimicrobial stewardship; Enterococci; Health-care–associated infections; Infection control; VRE
    • Accession Number:
      6Q205EH1VU (Vancomycin)
    • Publication Date:
      Date Created: 20211109 Date Completed: 20220301 Latest Revision: 20220301
    • Publication Date:
      20240829
    • Accession Number:
      10.1016/j.idc.2021.07.002
    • Accession Number:
      34752227